Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...

The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...

The scan included the cervical portion of the jugular vein to the subclavian confluence and the upper extremity axillary and the subclavian vein segment in its entirety except for the subclavian ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous ...

Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose ...

Three to four percent of cases of TOS are due to obstruction or clotting of the main vein to the arm - the subclavian vein - a condition called venous TOS. Venous TOS is commonly due to strenuous use ...

RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...

The femoral, jugular, subclavian, and cubital veins are the most frequently used sites for CVC insertion in children. In newborns, cubital veins and the saphenous vein are also frequently used for ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...